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Abstract
Surveillance data indicate that tick-borne diseases (TBDs) are a substantial public health problem 
in the United States, yet information on the frequency of tick exposure and TBD awareness and 
prevention practices among the general population is limited. The objective of this study was to 
gain a more complete understanding of the U.S. public’s experience with TBDs using data from 
annual, nationally representative HealthStyles surveys. There were 4728 respondents in 2009, 
4050 in 2011, and 3503 in 2012. Twenty-one percent of respondents reported that a household 
member found a tick on his or her body during the previous year; of these, 10.1% reported 
consultation with a health care provider as a result. Overall, 63.7% of respondents reported that 
Lyme disease (LD) occurs in the area where they live, including 49.4% of respondents from the 
West South Central and 51.1% from the Mountain regions where LD does not occur. Conversely, 
in the New England and Mid-Atlantic regions where LD, anaplasmosis, and babesiosis are 
common, 13.9% and 20.8% of respondents, respectively, reported either that no TBDs occur in 
their area or that they had not heard of any of these diseases. The majority of respondents (51.2%) 
reported that they did not routinely take any personal prevention steps against tick bites during 
warm weather. Results from these surveys indicate that exposure to ticks is common and 
awareness of LD is widespread. Nevertheless, use of TBD prevention measures is relatively 
infrequent among the U.S. public, highlighting the need to better understand barriers to use of 
prevention measures.
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Introduction
From 2009 to 2013, over 200,000 cases of tick-borne diseases (TBDs) were reported to the 
Centers for Disease Control and Prevention (CDC), including cases of anaplasmosis, 
babesiosis, ehrlichiosis, Lyme disease (LD), Rocky Mountain spotted fever (RMSF), and 
tularemia (Centers for Disease Control and Prevention, 2010, 2013). LD, caused by Borrelia 
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burgdorferi and transmitted by Ixodes spp. ticks, leads in number of cases with over 36,000 
confirmed and probable cases reported in 2013. Several novel tick-borne pathogens recently 
have been found to cause human illness in the United States: Borrelia miyamotoi, Ehrlichia 
species Wisconsin, and Heartland virus (Krause et al., 2013; Mcmullan et al., 2012; Pritt et 
al., 2011). In addition, southern tick-associated rash illness (STARI or Masters’ disease), 
which mimics the erythema migrans rash of early LD, is associated with the bite of the 
Amblyomma americanum tick but is of unknown etiology (Wormser et al., 2005). Diverse in 
their vectors, geographic distribution, and clinical manifestations, TBDs represent a 
substantial public health problem in the United States.
In the absence of available vaccines (Food and Drug Administration, 2002; Shen et al., 
2011) or easily implemented community-wide interventions, prevention of TBDs relies 
heavily on the consistent use of personal prevention measures and environmental tick 
controls on personal property (Connally et al., 2009; Curran et al., 1993; Schulze et al., 
1994, 1995; Stafford, 2004). Implementation of these measures is largely contingent upon 
individuals’ awareness of TBD risk where they live and recreate. Information on levels of 
TBD awareness and use of prevention measures among the U.S. public is lacking. In 
addition, several other important aspects of TBDs such as frequency of tick exposure and 
health care seeking behavior have not been quantified. Using data from nationwide 
HealthStyles surveys, this study was undertaken to gain a more complete understanding of 
the U.S. population’s experience with TBDs to guide prevention and control efforts.
Materials and methods
HealthStyles is an annual, cross-sectional, nationwide survey designed to be nationally 
representative based on U.S. Census Bureau demographics. Porter Novelli, a social 
marketing and public relations firm, has conducted the HealthStyles survey since 1995, and 
CDC annually licenses results from the survey post-collection. Survey questions aim to 
assess knowledge, attitudes, and behaviors for various health-related topics and to obtain 
information on self-reported diseases and conditions (Kennedy et al., 2011; Kobau et al., 
2006; Polen et al., 2015). In general, HealthStyles surveys demonstrate reliability and 
validity, showing concordance with the Behavioral Risk Factor Surveillance System on 
outcome levels, trends over time, and demographic breakdowns for similar health topics 
(Pollard, 2007).
HealthStyles survey respondents are randomly recruited each year from a large, nationally 
representative panel of non-institutionalized adults aged ≥18 years living in the contiguous 
United States and the District of Columbia. The 2009 HealthStyles survey was administered 
via mail, and the 2011 and 2012 surveys were administered online (Porter Novelli Public 
Services, 2009a, 2011a, 2012a). Each survey took approximately 40 minutes to complete. 
The specific questions regarding awareness of, prevention measures for, and experiences 
with TBDs are shown in Table 1 (Porter Novelli Public Services, 2009b, 2011b, 2012b). 
Response data were weighted using several demographic factors to ensure representativeness 
according to Current Population Survey (CPS) demographic proportions and to reduce 
potential nonresponse bias (US Census Bureau, 2006). (See Appendix A for details on 
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sampling methodologies and demographic factors used for weighting in 2009, 2011, and 
2012.)
For this study, reported frequencies are unweighted and reported proportions are weighted. 
Geographic regions are those designated by the U.S. Census Bureau (Fig. 1). Statistical 
analysis was conducted using IBM SPSS Statistics 21 (Armonk, NY: IBM Corp.). Analysis 
of 2009, 2011, and 2012 HealthStyles data was judged to be exempt from institutional 
review board requirements.
Results
Survey response rates were 73% (4728/6504) in 2009, 69% (4050/5864) in 2011, and 80% 
(3503/4371) in 2012 (P < .0001). For all three samples combined, 51.6% of respondents 
were female and 68.1% were white. Median respondent age was 51 years. Most respondents 
had an annual household income ≥$50,000 (55.8%), had some college education or higher 
(61.4%), and were employed (59.8%). Demographic characteristics of respondents matched 
the CPS proportions for each year (see Appendix B).
In 2009, 934 (21.0%) of 4728 total respondents reported that a household member found a 
tick on his or her body during the previous year; of these, 109 (10.1%) reported that a health 
care provider was consulted as a result of finding a tick on a household member. 
Respondents living in the West North Central, East South Central, and New England regions 
more commonly reported tick exposure in the household (36.7%, 32.2%, and 29.8%, 
respectively) (Fig. 1). Of all respondents reporting tick exposure in the household, health 
care provider consultation was most common in the New England (17.1%), Mid-Atlantic 
(17.0%), and Pacific (16.7%) regions and least common in the West South Central (2.4%), 
East South Central (3.0%), and West North Central (5.0%) regions.
Sixty (1.3%) respondents in 2009 and 43 (0.9%) in 2012 reported having been diagnosed 
with LD at some time in their lives. The percentage was highest in both years among 
respondents in the New England (6.5% in 2009, 2.2% in 2012) and Mid-Atlantic (3.0% in 
2009, 2.0% in 2012) regions. Among survey respondents in 2009 who reported past 
diagnoses with LD, the reported duration of antibiotic treatment was ≤4 weeks for 39.0% of 
respondents, 5–8 weeks for 20.3% of respondents, and >8 weeks for 35.6% of respondents. 
In the 2011 survey, respondents were asked about “chronic LD”; 17 (0.5%) said they had 
“chronic LD” and 516 (10.5%) said they knew someone else with “chronic LD.”
When asked which TBDs occur in the area where they live, respondents’ answers varied by 
disease and region (Table 2). Overall, 63.7% reported that LD occurs in the area where they 
live. Many respondents living in regions where LD is not known to occur, such as the East 
South Central, Mountain, and West South Central regions, reported that the disease occurs 
where they live (63.6%, 51.1%, and 49.4%, respectively). Overall, 20.2% of respondents 
reported that RMSF occurs in their area, with highest percentages in the Mountain (48.1%) 
and East South Central (38.3%) regions. In the New England and Mid-Atlantic regions, 
areas that have a high incidence of LD as well as anaplasmosis and babesiosis, 13.9% 
reported that no TBDs occur in their area and 20.8% said they had not heard of any of these 
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diseases. Regardless of region or endemicity, few respondents reported that the following 
diseases occur where they live: anaplasmosis (0.9%), babesiosis (1.1%), ehrlichiosis (1.4%), 
STARI (2.4%), tick-borne relapsing fever (1.9%), or tularemia (1.0%).
The majority of respondents (51.2%) reported that they did not routinely take any personal 
prevention steps against tick bites during warm weather (Table 3). Tick check was the most 
commonly reported personal prevention practice, with highest levels reported in West North 
Central (47.9%), East South Central (43.7%), and New England (43.2%) regions. Use of 
repellent was reported by respondents most commonly in the West North Central (30.3%), 
East South Central (27.6%), and West South Central (26.5%) regions, and showering to 
prevent tick bites was reported most commonly in the East South Central (26.6%), South 
Atlantic (21.4%), and West North Central (20.5%) regions.
Regarding environmental prevention measures, 10.7% of respondents reported using 
chemical pesticides to reduce ticks on their properties (Table 3). Highest rates of chemical 
pesticide use were reported by respondents in the West South Central (22.8%), East South 
Central (15.6%), and South Atlantic (13.0%) regions. In contrast, 10.2% of respondents 
overall reported that they would not use chemical pesticides on their property; respondents 
from the New England (14.1%) and Pacific (14.6%) regions were more commonly averse to 
chemical pesticide use.
Discussion
Results from these surveys suggest that exposure to ticks is common and awareness of at 
least one tick-borne disease (LD) is widespread in the United States. Nevertheless, use of 
measures to prevent TBDs is relatively infrequent, and there appear to be important gaps 
regarding awareness of other, non-Lyme TBDs among the U.S. public.
Reported exposure to ticks in households exceeded 18% in nearly all areas except the 
Mountain and Pacific regions. In New England, our results are similar to the 28% exposure 
rate reported by Gould et al. (2008) for endemic areas of Connecticut. In both the New 
England and Mid-Atlantic regions, a substantial proportion of respondents reported seeking 
care after tick exposure, likely driven by awareness of greater LD risk in those areas. 
Interestingly, in other regions, the frequency of tick exposure appears to be inversely related 
to care seeking, perhaps as a result of desensitization to tick exposures in areas with an 
abundance of ticks. For example, respondents in the West North Central and East South 
Central regions reported high rates of tick exposure but the lowest proportion of seeking 
health care for tick exposure. The inverse was true the Mountain and Pacific regions. It 
should be noted, however, that consultation with a healthcare provider for tick bite alone is 
not generally recommended, as antibiotic prophylaxis for tick bite has been validated only 
for the prevention of Lyme disease in very specific circumstances (Wormser et al., 2006).
A surprisingly large proportion of respondents reported receiving more than 8 weeks of 
antibiotic treatment for LD. While we cannot verify this time frame or determine the type of 
treatment prescribed or the rationale of the respondents’ providers, it should be emphasized 
that for early LD, which comprises the majority of LD cases, there is no scientific evidence 
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of clinical benefit from antibiotic treatment longer than current guidelines recommend 
(Kowalski et al., 2010; Wormser et al., 2003, 2006). Further, in patients with persistent 
symptoms and a history of LD, several controlled trials showed no benefit in prolonged 
antibiotic therapy (Klempner et al., 2001; Krupp et al., 2003). That many respondents 
reported receiving prolonged therapy is concordant with other reports of providers’ non-
adherence to or unfamiliarity with LD treatment guidelines (Eppes et al., 1994; Kowalski et 
al., 2010; Magri et al., 2002). Antimicrobial treatment for longer than guidelines recommend 
occurs commonly with other conditions and is not an indication that longer treatment 
courses are medically justified (Bratzler et al., 2005; Hecker et al., 2003; Kahan et al., 2004; 
Lee et al., 2014). Our results indicate that providers in LD endemic areas may benefit from 
education regarding the duration of therapy needed, especially in light of the risk of 
antibiotic-related complications and development of resistance.
The level of awareness of LD was high in all regions, especially among respondents in the 
New England and Mid-Atlantic regions, which account for a large proportion of reported 
cases (Centers for Disease Control and Prevention, 2013). This observation should be 
tempered, however, by the fact that 51–64% of respondents living in the East South Central, 
West South Central, and Mountain regions with no or very low incidences of LD reported 
that it occurs where they live. This misunderstanding is likely a result of widespread 
misinformation common on the internet (Cooper and Feder, 2004) and may result in patient 
requests for inappropriate diagnostic tests and treatment in these regions (Perea et al., 2014). 
TBD education efforts for the public and providers should take care in emphasizing the 
highly focal nature of TBDs, highlighting which diseases occur where and noting the 
possibility of travel-related cases.
Respondents in regions where RMSF occurs were somewhat familiar with the disease, but 
there is opportunity to increase awareness considering that the disease can become rapidly 
fatal if not treated promptly. In contrast, awareness of less common TBDs (anaplasmosis, 
babesiosis, and ehrlichiosis) was low in all regions. Fortunately, since Anaplasma 
phagocytophilum, Babesia microti, and Ehrlichia species Wisconsin are transmitted by the 
same Ixodes spp. ticks that transmit B. burgdorferi, those with awareness of LD who adopt 
prevention practices against these ticks will decrease their risk of acquiring other TBDs as 
well.
Despite the high numbers of tick exposures and high LD awareness reported by respondents 
in the New England and Mid-Atlantic regions, the proportion of respondents in these regions 
routinely practicing personal prevention methods is lower than what has been reported in the 
literature for highly endemic areas (Herrington et al., 1997; Phillips et al., 2001; Shadick et 
al., 1997). In addition, a lower proportion of respondents in these regions reported current 
use of chemical pesticides to reduce ticks on properties, and a high proportion reported that 
they would not consider using these pesticides when compared with other regions. However, 
the low levels of use of personal and environmental prevention measures reported in this 
study may be due to the inclusion of respondents who infrequently encounter tick habitat 
and therefore have little need to take precautions. Alternatively, it may suggest that even 
with adequate levels of knowledge and awareness, additional barriers exist among the public 
toward adopting prevention measures, such as knowledge of effectiveness, affordability, 
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accessibility, and perceptions of risk (Gould et al., 2008). Future research should determine 
the specific reasons why people choose not to implement certain measures. Once these 
barriers are understood, intensive educational interventions promoting acceptable, validated 
methods may increase prevention practices among the public in areas of tick-borne disease 
risk (Daltroy et al., 2007).
Our findings are subject to several limitations. First, all data collected in the HealthStyles 
surveys were self-reported, may be subject to recall bias, and could not be independently 
validated. Second, reporting weighted proportions allows for better accuracy in terms of the 
representativeness of responses to the U.S. population; however, these weighted proportions 
are notably discrepant from the unweighted proportions (not reported) for survey questions 
with a small number of responses. Third, our results do not include data for persons under 
18 years of age who account for a quarter of all reported LD cases. Fourth, the census 
regions used for our assessments do not coincide precisely with areas of endemicity for 
certain TBDs and do not allow for finer-scale evaluations of TBD risk in relation to reported 
prevention practices or disease awareness. Further, some of the survey questions are subject 
to variable interpretation. For example, for the question related to TBD occurrence, the 
phrase, “the area where you live,” could have been interpreted by respondents to mean their 
region, state, county, or municipality. For the survey questions on LD diagnoses, diagnosis 
requirements such as physician-diagnosed LD or laboratory evidence of infection were not 
defined. Further, the term “chronic LD” was not defined in the survey because it is in 
common usage among the public, particularly on the internet; it is typically used to describe 
a range of conditions which may or may not be associated with B. burgdorferi infection; and 
it currently has no agreed upon clinical definition (Marques, 2008). Finally, English 
language literacy is required to participate in HealthStyles surveys; therefore, some 
individuals with low literacy in English may have been underrepresented.
These limitations notwithstanding, the HealthStyles surveys had robust sample sizes, 
relatively high response rates, and used post-stratification weighting to ensure 
representativeness to the U.S. population. These findings serve as a baseline for future, 
annual use of HealthStyles surveys to evaluate TBD awareness, prevention practices, self-
reported tick exposures, and LD diagnoses over time, increasing the validity and reliability 
of the current findings. In conclusion, results from the national HealthStyles surveys 
contribute to a more accurate picture of the overall burden of TBDs in the United States and 
highlight opportunities for targeted TBD health communications as well as the need to better 
understand barriers to use of prevention measures by the public.
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Fig. 1. 
Tick exposure and health care seeking by region (2009).
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Table 1
HealthStyles tick-borne disease survey questions and year questions were asked.
1. “In the last year, did anyone in your household find a tick on their body?” Select one: Yes; No; Not sure (2009)
2. “If yes, did this person consult a health care provider because of finding a tick?” Select one: Yes; No; Not sure (2009)
3.
“Have you ever been diagnosed with Lyme disease?” Select one: Yes; No; Not sure (2009, 2012)a
4. “If yes, how long were you treated with antibiotics?” Select one: 4 weeks or less; 5–8 weeks; Longer than 8 weeks; I did not receive 
antibiotic treatment (2009)
5. “Do you personally know anyone who describes themselves as having chronic Lyme disease?” Select all that apply: Yes, I know someone; 
No, I do not know anyone; I suffer from chronic Lyme disease (2011)
6. “Which of the following diseases spread by ticks occur in the area where you live?” Select all that apply: Lyme disease; Rocky Mountain 
spotted fever; Anaplasmosis; STARI or Southern Tick-Associated Rash Illness; Ehrlichiosis; Tularemia; Babesiosis; Tick-borne Relapsing 
Fever; None of these diseases occur in my area; I have not heard of any of these (2009)
7. “Would you use chemical pesticides up to one or two times per year if they would meaningfully reduce the number of ticks in your yard/on 
your property?” Select one: I already use them; Yes, I would consider them; Maybe I would use them; No, I would not use them; Not sure; 
Don’t have a yard/land (2009)
8. “When the weather is warm in your area, what steps, if any, do you routinely take to prevent tick bites?” Select all that apply: I wear 
repellent; I shower soon after coming indoors; I check my body for ticks when I come in; I take other steps that are not listed above; I do 
not take any steps to prevent ticks bites (2011)
a
In 2012, respondents were asked, “Have you ever been diagnosed with Lyme disease?” Response options included: “No; Yes, within the past the 
past 6 months; Yes, 7–11 months ago; Yes, 1–2 years ago, Yes, 3–5 years ago; Yes, more than 5 years ago.” Due to a small number of responses for 
any of the “Yes” options, these responses were collapsed into a single “Yes” for those who reported ever having been diagnosed with LD.
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Table 2
Number of respondents who believe that the indicated TBD occurs in the area where they live (2009).
Geographic region LD
n (% within
region)
RMSF
n (% within
region)
None or “Have not
heard of any of these
TBDs”a
n (% within region)
Overall 2943 (63.7) 959 (20.2) 1559 (31.6)
New England 170 (86.1) 18 (11.5) 30 (13.9)
Mid-Atlantic 502 (78.7) 64 (7.6) 146 (20.8)
East North Central 552 (68.6) 89 (10.9) 234 (28.6)
West North Central 242 (77.9) 82 (20.6) 70 (19.3)
South Atlantic 597 (66.2) 265 (28.3) 289 (28.8)
East South Central 206 (63.6) 122 (38.3) 109 (30.2)
West South Central 242 (49.4) 110 (25.8) 236 (45.4)
Mountain 157 (51.1) 148 (48.1) 116 (30.3)
Pacific 275 (38.9) 61 (9.5) 329 (55.1)
a
The TBDs listed in this survey question were Lyme disease, RMSF, anaplasmosis, babesiosis, ehrlichiosis, STARI, tick-borne relapsing fever, and 
tularemia (Table 1).
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